Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study

Gastroenterology

Volumn 102, Issue 1, 1992, Pages 109-118

  Sontag, Stephen J ^a   Hirschowitz, Basil I ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Holt, Stephen ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Robinson, Malcolm G ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Behar, Jose ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Berenson, Malcolm M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Mccullough, Arthur ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Ippoliti, Andrew F ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Richter, Joel E ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Ahtaridis, George ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   McCallum, Richard W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Pambianco, Daniel J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Vlahcevic, Reno Z ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Johnson, David A ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Collen, Martin J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Lyon, David T ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Humphries, Thomas J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Cagliola, Angeline ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Berman, Rayanne S ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^g METROHEALTH MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j GRADUATE HOSPITAL   (United States)

^k UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^l VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^m WALTER REED ARMY MEDICAL CENTER   (United States)

ⁿ LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^o LONG ISLAND COLLEGE HOSPITAL   (United States)

^p MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ATTAPULGITE; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG DOSE; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; EROSIVE GASTRITIS; FOOD INTAKE; HEADACHE; HEARTBURN; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RASH; SMOKING; SYMPTOMATOLOGY; ULCER HEALING; UNITED STATES; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGITIS; ESOPHAGOSCOPY; HUMAN; MIDDLE AGE; OMEPRAZOLE; PLACEBOS; STOMACH DISEASES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026570551     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(92)91790-B     Document Type: Article

References (35)

1. Why do apparently healthy people use antacid tablets?
2. Symptomatic gastroesophageal reflux: incidence and precipitating factors
3. Endoscopic screening for Barrett's esophagus, esophageal adenocarcinoma and other mucosal changes in ambulatory subjects with symptomatic gastroesophageal reflux (abstr)
4. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects
5. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis
6. Twenty-four-hour pH monitoring of the distal esophagus: a quantitative measure of gastroesophageal reflux
7. Oesophageal acid clearing: one factor in the production of reflux oesophagitis
8. Acid clearance during sleep in the pathogenesis of reflux esophagitis
9. Gastric emptying in patients with gastroesophageal reflux
10. Gastric distention: a mechanism for postprandial gastroesophageal reflux
11. Definition of the gastric emptying abnormality present in gastroesophageal reflux patients
12. Role of bile and pancreatic juice in production of esophageal erosions and anemia
13. Esophagitis following total gastrectomy
14. Subacute erosive esophagitis associated with achlorhydria
15. Effect of bile salts on the ionic permeability of the esophageal mucosa and their role in the production of esophagitis
16. Role of acid and pepsin in acute experimental esophagitis
17. Consequences of gastroesophageal reflux
18. Patterns of gastroesophageal reflux in health and disease
19. How do 24-hour pH measurements distinguish the disease spectrum of reflux patients (abstr)
20. Optimal dose of oral omeprazole for maximal 24-hour decrease of intra-gastric acidity
21. Effect of omeprazole, a substituted benzimidazole, on 24-hour intragastric acidity in patients with peptic ulcer disease
22. Effect of daily oral omeprazole on 24-hour intragastric acidity
23. Statistical aspects of the analysis of data from retrospective studies of disease
24. Evaluation of survival data and two new rank order statistics arising in its consideration
25. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples
26. Healing and relapse of severe peptic esophagitis after treatment with omeprazole
27. Omeprazole versus ranitidine in the treatment of reflux esophagitis. Results of a randomized, double-blind, multicenter French-Belgian study
28. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study
29. Omeprazole and ranitidine in treatment of reflux oesophagitis: double-blind comparative trial
30. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
31. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis
32. Double-blind comparative study of omeprazole 40 mg once daily vs cimetidine 400 mg qd in the treatment of erosive reflux oesophagitis (abstr)
33. Comparison of the effects of two doses of omeprazole on 24-hour esophageal pH in gastroesophageal reflux disease (abstr)
34. Omeprazole dose response effect on 24-hour esophageal acid exposure in patients with symptomatic gastroesophageal reflux disease: a four-way crossover study (abstr)
35. Ranitidine therapy for gastroesophageal reflux disease: results of a large double-blind trial